Yesterday I posted summaries for three analyst conferences reporting Q2 results. The most dramatic result was the swoon in Dendreon's stock price. It is a busy day, so all I can do right now is provide links to my summaries:
Dendreon (DNDN) Q2 2011 analyst conference call summary
Onyx Pharmaceutical (ONXX) Q2 2011 analyst conference call summary
Hansen Medical (HNSN) Q2 2011 analyst conference call summary
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment